Close Menu

radiation exposure

The researchers are aiming to find molecular signatures in blood that identify previous exposures to materials associated with weapons of mass destruction.

The Biomedical Advanced Research and Development Authority aims to produce at least two US Food and Drug Administration-cleared tests.

DxTerity aims to develop a genomic blood test to identify which cancer patients are most likely to benefit from radiation therapy or are at risk for toxicity.

With exome sequences, RNA sequences, and methylation profiles, investigators uncovered differences between radiation-induced and sporadic forms of meningioma.

The developers said such a signature could help triage people exposed to radiation through war, a terrorist attack, or an industrial accident.

In Science this week: DNA Fountain for storing data in DNA, and more.

The firm plans to seek Emergency Use Authorization for the 18-gene panel and will subsequently submit it to the FDA for full approval.

Genome sequencing suggests secondary tumors present after ionizing radiation treatment tend to contain numerous deletions and balancing inversions.

The additional funds bring the total contract to $43 million over approximately eight years.

NEW YORK (GenomeWeb) – The National Institute of Allergy and Infectious Diseases plans to provide $21 million next year to support a network of research centers that will develop medical countermeasures, including biomarkers and diagnostics tools, for radiological or nuclear emergencies.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.